Please assess the completion status of the following clinical trial:

Trial Title: MK0954A-264 Filter Study (0954A-264)(COMPLETED)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male and female patients with mild to severe hypertension (SiDBP 90-120 mmHg)~Exclusion Criteria:~* Systolic BP \> 200 mmHg~* Secondary or malignant hypertension~* Taking more than 2 antihypertensive medications~* Hypertension induced by oral contraceptives~* Hx of cerebral vascular accident within 6 months~* Hx of angina, myocardial infarction, PCI, CABG, or decompensated CHF within 6 months~* Clinically significant AV conduction disturbance or potentially life threatening ventricular arrhythmias, valvular disease, cardiomyopathy, unexplained syncope~* History of angioedema~* Sensitivity to AII receptor antagonists or HCTZ, nephrotic syndrome,single kidney function~* Pregnancy or lactation.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).